SU1356287A1 - METHOD OF OBTAINING IMMUNE SERIES - Google Patents

METHOD OF OBTAINING IMMUNE SERIES

Info

Publication number
SU1356287A1
SU1356287A1 SU3544820/14A SU3544820A SU1356287A1 SU 1356287 A1 SU1356287 A1 SU 1356287A1 SU 3544820/14 A SU3544820/14 A SU 3544820/14A SU 3544820 A SU3544820 A SU 3544820A SU 1356287 A1 SU1356287 A1 SU 1356287A1
Authority
SU
USSR - Soviet Union
Prior art keywords
obtaining immune
donors
antigen
series
immune series
Prior art date
Application number
SU3544820/14A
Other languages
Russian (ru)
Inventor
В.М. Свистунов
Ю.В. Гуров
В.В. Сухов
И.И. Черченко
В.И. Ястребов
Л.К. Камышова
Original Assignee
Волгоградский научно-исследовательский противочумный институт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Волгоградский научно-исследовательский противочумный институт filed Critical Волгоградский научно-исследовательский противочумный институт
Priority to SU3544820/14A priority Critical patent/SU1356287A1/en
Application granted granted Critical
Publication of SU1356287A1 publication Critical patent/SU1356287A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Способ получения иммунных сывороток, включающий чрезкожное введение антигена группе доноров с последующим забором крови и выделением из нее сыворотки, отличающийся тем, что, с целью повышения стандартного содержания специфических антител за счет снижения разброса в титрах антител, антиген вводят всем донорам в одни и те же топографически определенные места кожи.A method of obtaining immune sera, including percutaneous administration of an antigen to a group of donors, followed by blood sampling and separation of serum from it, characterized in that, in order to increase the standard content of specific antibodies by reducing the variation in antibody titers, the antigen is administered to all donors in the same topographically defined skin areas.

SU3544820/14A 1983-01-21 1983-01-21 METHOD OF OBTAINING IMMUNE SERIES SU1356287A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU3544820/14A SU1356287A1 (en) 1983-01-21 1983-01-21 METHOD OF OBTAINING IMMUNE SERIES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU3544820/14A SU1356287A1 (en) 1983-01-21 1983-01-21 METHOD OF OBTAINING IMMUNE SERIES

Publications (1)

Publication Number Publication Date
SU1356287A1 true SU1356287A1 (en) 1999-04-10

Family

ID=60517603

Family Applications (1)

Application Number Title Priority Date Filing Date
SU3544820/14A SU1356287A1 (en) 1983-01-21 1983-01-21 METHOD OF OBTAINING IMMUNE SERIES

Country Status (1)

Country Link
SU (1) SU1356287A1 (en)

Similar Documents

Publication Publication Date Title
Hudson et al. Immunodepression, high IgM levels and evasion of the immune response in murine trypanosomiasis
IL73437A (en) Method and test kit for detecting immune(clq)complexes in human serum by means of a mouse monoclonal antibody
FI800140A (en) FOERFARANDE FOER DETEKTERING AV HEMOGLOBIN I AVFOERING
ATE82072T1 (en) IMMUNOASSAY AND -ROLYMERIC IGG DERIVATIVES FOR COMPENSATION OF INTERFERENCE FACTORS IN IMMUNOASSAYS.
ES483313A1 (en) Immunological determination process.
ATE67313T1 (en) DETECTION OF HUMAN CYTOMEGALOVIRUS-SPECIFIC IGM.
EP0248534A3 (en) Method of detecting aids virus infection
AU6828387A (en) Assay for human breast cancer
Swedlund et al. Comparison of certain properties of naturally occurring low molecular weight γM and the γM monomer derived by reduction and alkylation of 19 S γM
SU1356287A1 (en) METHOD OF OBTAINING IMMUNE SERIES
Griscelli et al. Congenital toxoplasmosis: Fetal synthesis of oligoclonal immunoglobulin G in intrauterine infection
Houba et al. Serum immunoglobulins in juvenile rheumatoid arthritis.
ES8401261A1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor.
ES8106834A1 (en) Antibody serum
EP0248147A3 (en) Method of determining the presence of cancer cells
Matsuoka et al. Isolation and characterization of IgA produced by an established human lymphocytoid cell line
Papenhausen et al. Complement receptor in synchronized cultures of human hematopoietic cell lines
Harris et al. SHIFTS FROM IgG2 CLASS TO IgG1 CLASS IN CBA AND C3H ANTI-BALB/c ANTIBODY
Schwab AN INTRACELLULAR HEMOLYSIN OF GROUP A STREPTOCOCCI III: Immunological Studies
Wilson et al. Immunoglobulin characteristics of antibodies to malarial S-antigens in man
UA14123A1 (en) Method for obtaining anti-proteus plasma
Anderson-Visoná et al. Identity of antibody to hepatitis B e/1 antigen as an atypical rheumatoid factor
SU1373169A1 (en) Method of immunization of animals
SU668684A1 (en) Method of preparing standard anti-rh serum
Dandliker et al. Kinetic investigations of antigen-antibody and hapten-antibody reactions